Skip to main content

Advertisement

SpringerLink
Log in

Late occurrence of Epstein-Barr virus-associated lymphoproliferative disorder in a patient with follicular lymphoma treated with bendamustine and rituximab

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Rummel MJ, Niederle N, Maschmeyer G et al (2013) Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet 381:1203–1210

    Article  CAS  PubMed  Google Scholar 

  2. Flinn IW, Van Der Jagt R, Kahl BS et al (2014) Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study. Blood 123:2944–2952

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. García Muñoz R, Izquierdo-Gil A, Muñoz A et al (2014) Lymphocyte recovery is impaired in patients with chronic lymphocytic leukemia and indolent non-Hodgkin lymphomas treated with bendamustine plus rituximab. Ann Hematol 93:1879–1887

    Article  PubMed  Google Scholar 

  4. Hosoda T, Yokoyama A, Yoneda M et al (2013) Bendamustine can severely impair T-cell immunity against cytomegalovirus. Leuk Lymphoma 54:1327–1328

    Article  CAS  PubMed  Google Scholar 

  5. Hasegawa T, Aisa Y, Shimazaki K, Nakazato T (2015) Cytomegalovirus reactivation with bendamustine in patients with low-grade B-cell lymphoma. Ann Hematol 94:515–517

    Article  PubMed  Google Scholar 

  6. Lane MA, Renga V, Pachner AR, Cohen JA (2015) Late occurrence of PML in a patient treated for lymphoma with immunomodulatory chemotherapies, bendamustine, rituximab, and ibritumomab tiuxetan. Case Rep Neurol Med. doi:10.1155/2015/892047

    PubMed Central  PubMed  Google Scholar 

  7. Swerdlow SH, Campo E, Harris NL et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer Press, Lyon

    Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

Informed consent was obtained from the patient described.

Author information

Authors and Affiliations

  1. School of Medicine, University of Tsukuba, Tsukuba, Japan

    Kei Muroi

  2. Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan

    Mamiko Sakata-Yanagimoto, Yasuhisa Yokoyama, Naoki Kurita, Naoshi Obara, Yuichi Hasegawa & Shigeru Chiba

  3. Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan

    Mamiko Sakata-Yanagimoto, Yasuhisa Yokoyama, Naoki Kurita, Naoshi Obara, Yuichi Hasegawa & Shigeru Chiba

  4. Department of Pathology, University of Tsukuba Hospital, Tsukuba, Japan

    Taiki Sato

  5. Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan

    Koichiro Maie

  6. Department of Pathology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

    Masayuki Noguchi

Authors
  1. Kei Muroi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mamiko Sakata-Yanagimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Taiki Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yasuhisa Yokoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Koichiro Maie
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Naoki Kurita
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Naoshi Obara
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yuichi Hasegawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Masayuki Noguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Shigeru Chiba
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shigeru Chiba.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Muroi, K., Sakata-Yanagimoto, M., Sato, T. et al. Late occurrence of Epstein-Barr virus-associated lymphoproliferative disorder in a patient with follicular lymphoma treated with bendamustine and rituximab. Ann Hematol 94, 2061–2062 (2015). https://doi.org/10.1007/s00277-015-2463-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-015-2463-3

Keywords

Search

Navigation